Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-032601)

Filing Details

Accession Number:: 0001209191-13-032601
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-06-18 10:34:17
Reporting Period:: 2013-06-17

Filing Date:: 2013-06-18
Accepted Time:: 2013-06-18 10:34:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
59478	Lilly Eli & Co	LLY	Pharmaceutical Preparations (2834)	350470950

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1476151	A Enrique Conterno	Lilly Corporate Center Indianapolis IN 46285	Sr. Vp & Pres., Lilly Diabetes	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-06-17	5,000	$52.45	67,177	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,461	Indirect	401(k)

Footnotes

The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2013.